Literature DB >> 8253462

Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.

L Quintanilla-Martinez1, E W Wilkins, J A Ferry, N L Harris.   

Abstract

We applied the classification system of Marino and Müller-Hermelink (Virchows Arch A Pathol Anat Histopathol 407:119-149, 1985) and Kirchner and Müller-Hermelink (Prog Surg Pathol 10: 167-189, 1989) to 122 thymic epithelial tumors to evaluate the utility of this classification and to determine its correlation with invasiveness, follicular lymphoid hyperplasia, myasthenia gravis, and immunophenotype. The majority of cases could be classified according to this scheme: eight cases (7%) were medullary thymoma, 34 cases (28%) were mixed thymoma, 20 cases (16%) were predominantly cortical (organoid) thymoma, 22 cases (18%) were cortical thymoma, 32 cases (26%) were well-differentiated carcinoma (WDC), two cases (2%) were high-grade carcinoma, and four cases (3%) were unclassifiable. We report a detailed histologic analysis of these subtypes, with criteria for diagnosis. We propose that the term "organoid thymoma" be replaced by "predominantly cortical thymoma." We also observed a previously unrecognized subtype of WDC with spindle-shaped epithelial cells, which must be distinguished from medullary thymoma. There was a strong correlation between histologic subtype and invasion (P < .0001). All medullary and mixed thymomas were either completely encapsulated (64%) or had only invasion through the capsule (36%). Organoid and cortical thymomas showed an intermediate degree of invasiveness, with 36% invasive into mediastinal fat and 14% into adjacent structures. All the cases of WDC were invasive either through the capsule (19%) or into adjacent structures (81%); five cases (16%) also showed distant spread in the form of pleural seeding (four cases) or lymph node metastasis (one case). Microscopic evaluation disclosed invasion in a substantial number of cases (28.5%) thought by the surgeon to be encapsulated. The presence of follicular lymphoid hyperplasia, either within the tumor, in the residual normal thymus, or in both, was a significant predictor of myasthenia gravis (P < .0015); there was an increased association of myasthenia gravis and thymomas with cortical type epithelium (organoid thymoma, cortical thymoma, and WDC). There was no correlation between epithelial cell morphology and antigen expression; however, the immunophenotype of the associated lymphocytes corresponded closely to the morphologic classification of the thymomas. The Müller-Hermelink morphologic classification can be applied to most cases of thymoma and strongly predicts invasive behavior. The correlation of lymphocyte immunophenotype with the morphologic classification of the epithelial cells suggests that it is biologically accurate.

Entities:  

Mesh:

Year:  1993        PMID: 8253462     DOI: 10.1016/0046-8177(93)90109-t

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  MR imaging of thymic epithelial tumors: correlation with World Health Organization classification.

Authors:  Atsuo Inoue; Noriyuki Tomiyama; Kiminori Fujimoto; Junko Sadohara; Itsuko Nakamichi; Yasuhiko Tomita; Katsuyuki Aozasa; Mitsuko Tsubamoto; Sachiko Murai; Javzandulam Natsag; Hiromitsu Sumikawa; Naoki Mihara; Osamu Honda; Seiki Hamada; Takeshi Johkoh; Hironobu Nakamura
Journal:  Radiat Med       Date:  2006-04

2.  Multi-institutional European experience of robotic thymectomy for thymoma.

Authors:  Giuseppe Marulli; Jos Maessen; Franca Melfi; Thomas A Schmid; Marlies Keijzers; Olivia Fanucchi; Florian Augustin; Giovanni M Comacchio; Alfredo Mussi; Monique Hochstenbag; Federico Rea
Journal:  Ann Cardiothorac Surg       Date:  2016-01

3.  Thymic epithelial tumors can develop along two different pathogenetic pathways.

Authors:  R Zhou; A Zettl; P Ströbel; K Wagner; H K Müller-Hermelink; S Zhang; A Marx; P Starostik
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Recurrent genetic aberrations in thymoma and thymic carcinoma.

Authors:  A Zettl; P Ströbel; K Wagner; T Katzenberger; G Ott; A Rosenwald; K Peters; A Krein; M Semik; H K Müller-Hermelink; A Marx
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Thymoma: a review of the clinical and pathological findings in 65 cases.

Authors:  Brita Sperling; Jeff Marschall; Renee Kennedy; Punam Pahwa; Rajnl Chibbar
Journal:  Can J Surg       Date:  2003-02       Impact factor: 2.089

6.  Clinical and pathologic predictors of survival in patients with thymoma.

Authors:  K B Wilkins; E Sheikh; R Green; M Patel; S George; M Takano; M Diener-West; J Welsh; S Howard; F Askin; G B Bulkley
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

Review 7.  Robotic-assisted thymectomy: current perspectives.

Authors:  Giuseppe Marulli; Giovanni M Comacchio; Francesca Stocca; Davide Zampieri; Paola Romanello; Francesca Calabrese; Alessandro Rebusso; Federico Rea
Journal:  Robot Surg       Date:  2016-09-07

8.  Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Authors:  David Suster; James A Miller; German Pihan; A Craig Mackinnon; Saul Suster
Journal:  Mod Pathol       Date:  2021-06-16       Impact factor: 7.842

9.  Cervical type AB thymoma (Mixed) tumour diagnosis in a mynah as a model to study human: clinicohistological, immunohistochemical and cytohistopathological study.

Authors:  Fariba Khaki; Javad Javanbakht; Farhang Sasani; Mohammad Javad Gharagozlou; Alimohammad Bahrami; Hemmat Moslemzadeh; Reza Sheikhzadeh
Journal:  Diagn Pathol       Date:  2013-06-18       Impact factor: 2.644

10.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.

Authors:  Gui Youn Lee; Woo Ick Yang; Hei Cheul Jeung; Sang Chul Kim; Min Young Seo; Chan Hee Park; Hyun Cheol Chung; Sun Young Rha
Journal:  BMC Genomics       Date:  2007-09-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.